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Abstract
Background and aims: Chronic kidney disease (CKD) is a public health challenge worldwide, with 
adverse consequences of kidney failure, cardiovascular disease (CVD), and premature death. The CKD 
leads to the end-stage of renal disease (ESRD) if late/not diagnosed. Competing risk modeling is a 
major issue in epidemiology research. In epidemiological study, sometimes, inappropriate methods 
(i.e. Kaplan-Meier method) have been used to estimate probabilities for an event of interest in the 
presence of competing risks. In these situations, competing risk analysis is preferred to other models 
in survival analysis studies. The purpose of this study was to describe the bias resulting from the use 
of standard survival analysis to estimate the survival of a patient with ESRD and to provide alternate 
statistical methods considering the competing risk.
Methods: In this retrospective study, 359 patients referred to the hemodialysis department of Shahid 
Ayatollah Ashrafi Esfahani hospital in Tehran, and underwent continuous hemodialysis for at least 
three months. Data were collected through patient’s medical history contained in the records (during 
2011-2017). To evaluate the effects of research factors on the outcome, cause-specific hazard model 
and competing risk models were fitted. The data were analyzed using Stata (a general-purpose 
statistical software package) software, version 14 and SPSS software, version 21, through descriptive 
and analytical statistics.
Results: The median duration of follow-up was 3.12 years and mean age at ESRD diagnosis was 
66.47 years old. Each year increase in age was associated with a 98% increase in hazard of death. In 
this study, statistical analysis based on the competing risk model showed that age, age of diagnosis, 
level of education (under diploma), and body mass index (BMI) were significantly associated with 
death (hazard ratio [HR] = 0.98, P < 0.001, HR = 0.99, P < 0.001, HR = 2.66, P = 0.008, and HR = 0.98, 
P < 0.020, respectively).
Conclusion: In analysis of competing risk data, it was found that providing both the results of the 
event of interest and those of competing risks were of importance. The Cox model, which ignored 
the competing risks, presented the different estimates and results as compared to the proportional 
sub-distribution hazards model. Thus, it was revealed that in the analysis of competing risks data, the 
sub-distribution proportion hazards model was more appropriate than the Cox model.
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Introduction 
The chronic kidney disease (CKD) is known as a global 
health problem. This disorder gradually leads to end 
stage of  renal disease (ESRD). The ESRD is defined as 
reduction of  the amount of  glomerular filtration rate 
(GFR) to less than 15 ml/m /per 1.73 m2.1 In the absence 
of  national registries, no reliable data are available on 
the incidence and prevalence of  ESRD in Iran. Due 
to an increase in life expectancy in Iranian context, the 
contribution of  ESRD related to the death factors is 
increasing. The prevalence and incidence of  patients with 
ESRD based on the latest available statistics for the year 
2006 were as follows: 434.83 and 63.8 in each million/
year as well as the annual rate of  the disease at the end 
of  that year which was estimated between 4% and 5%.2
The survival of  ESRD patients is lower than that 
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of  the general population.3 The classic example is to 
consider the various causes of  death. If  a subject dies of 
one particular cause he/she is no longer at risk of  death 
owing to any other cause. Two specific examples in the 
nephrology world that require competing risk analysis 
are comparisons of  mortality risk in patients with CKD 
compared with the mortality risks of  those patients 
who have developed ESRD, since the risk of  mortality 
is different for patients who reach ESRD as compared 
to those who do not progress to it.4 In the traditional 
analysis of  this data, most researchers were interested 
in knowing the distribution of  observed survival times 
in a particular refractive index and all other factors as 
censored data.
In cohort studies and clinical trials, the incidence 
of  an event is often investigated. Competing risk data 
occurs when the subjects under study have more than 
one single event, such as death, from various causes. 
The term competing risks also refer to data in which 
different events may not be mutually exclusive but 
interest in the first event occurs5 the most common of 
which are the competing risks of  relapse and death in 
remission. These two risks are the primary reasons that 
patients fail treatment. In most epidemiological papers 
the effects of  covariates on three outcomes (relapse, 
death in remission, and treatment failure) are modeled 
by distinct proportional hazards regression models. 
Standard survival analyses might overestimate the rate 
of  the event, especially when the rate of  the competing 
risk is high. The presence of  competitive risks is time-to-
time analysis and standard survival analysis is not always 
appropriate and thus should be interpreted with care.6 
In addition, competing risks refer to situations in which 
different types of  events might occur. For example, when 
studying death on dialysis, receiving a kidney transplant 
is an event that competes with the event of  interest. 
Thus, a competing risk is an event that either prevents 
the event from being viewed or changes the chance of 
the event.7 The aim of  this study was to demonstrate the 
practicality of  competing risk models, to estimate the 
survival of  ESRD patients using competing risk analysis, 
and also to compare its results with other commonly 
used approaches.
Methods 
We performed a retrospective study among all ESRD 
patients older than 20 years who were registered (during 
2011 to 2017) in the hemodialysis department of  Shahid 
Ayatollah Ashrafi Esfahani hospital, Tehran, Iran. Patient 
were included in the study when renal replacement therapy 
such as hemodialysis was initiated. Those patients who 
died within three months following the onset of  dialysis 
were excluded from the study. The collected data included 
information and characteristics, clinical characteristics, 
transplantation history, hemodialysis, and also the cause 
of  the end-stage renal disease. The event of  interest 
were death and transplantation.  Myocardial infarction, 
stroke, cancer, hepatitis C, accidents, sepsis, cardiac and 
respiratory arrest, seizures, diabetic foot, and embolism 
were considered to be as competing risks. Gender, age, 
body mass index (BMI), blood markers, blood pressure, 
diabetes, smoking, education level, marital status, 
and blood group were considered to be independent 
variables. Two different models were used to fit the 
data. In the first model, data were analyzed applying the 
competing risk approach as explained by Fine and Gray. 
They proposed the direct use of  a regression model on 
a cumulative incidence function. The second model that 
was employed to fit the data was a specific hazard model. 
In the following sections, a brief  introduction is provided 
regarding the concepts of  these models.
Statistical Methods for the Analysis of  Survival Data in 
the Presence of  Competing Risks
Gray and Fine Models
The model proposed by Fine and Gray is based on 
the hazard of  the sub-distribution and provides a 
simple relationship between covariates and cumulative 
incidence.8 In this model, the effect of  independent 
variables, in contrast to the direct cause-specific model, 
is examined on the cumulative incidence function. 
Therefore, the effect of  an independent variable in this 
model would be very different from its effect in cause-
specific model.9 In other words, this model seeks to model 
the cumulative incidence function. Given the definition 
of  the cumulative incidence function as the probability 
of  the given incident occurrence before the specified 
time T and prior to the occurrence of  the competing 
incidents, by defining the cumulative incidence function 
for each incident, for example, for the first incident, this 
model will be as follows: 
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difference between this model and the cause-specific model is the number of individuals 
at risk for the given incident. In the cause-specific model, the number of individuals at 
risk is reduced each time a person experiences the rest causes. But in this model, in which 
the person is experiencing other causes, it is assumed at the risk remained that  the time 
for these individuals has been censored which is longer than all the times of the given 
incident. This leads to the cumulative incidence function's association with only one's 
own hazard function for a specific cause and not the rest of the hazards. 
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by time t 6. In this classic analysis, there is a favorite event and all other events are 
censored. The assumption of this method is that of non-informative censoring which is 
based on the idea that censored patients are more likely to experience the event as follow-
where β is the vector of  regression coefficients and 
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λ10(t) displays a nonparametric estimation of  the baseline 
hazard. Combining the two recent equations, the 
cumulative incidence function for the first incident will 
be as follows:
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In this model, the nonparametric estimation of  the 
cumulative incidence functions, of  course, is calculated 
wi  som  changes relative to th  cause-specific model. 
The difference betwe n this model and the cause-
specific model is the number of  individual  at risk for 
the given incident. In the cause-specific model, the 
number of  individuals at risk is reduced each time a 
person experiences the rest causes. But in this model, 
in which the person is experiencing other causes, it is 
assumed at the risk remained that the time for these 
individuals has been censored which is longer than all the 
times of  the given incident. This leads to the cumulative 
incidence function’s association with only one’s own 
hazard function for a specific cause and not the rest of 
the hazards.
Cumulative Incidence Function
A second statistical method in competing risks is the 
cumulative incidence function. This function is directly 
estimable from the data without a need for making any 
distributio l assumptions. Standard survival analysis 
methods have been commonly used to analyze the
competing risks data. H wev r, somet mes, inappropriate 
methods such as the complement of  Kaplan-Meier 
estimate (1-KM) has been applied to estimate the 
probabilities of  the occurrence of  an event of  interest 
in a competing risks setting.10,11 The 1-KM cannot be 
interpreted as the actual probability of  the occurrence 
of  an event by time t.6 In this classic analysis, there is 
a favorite event and all other events are censored. The 
assumption of  this method is that of  non-informative 
censoring which is based on the idea that censored 
patients are more likely to experience the event as follow-
up patients. However, this assumption has not been 
confirmed in the presence of  numerous competing 
results.12 These estimates have been interpreted as the 
probability of  an ideal event in the ideal world in which 
there are no other types of  events.6,8 Although, in the 
presence of  competing risks, each event has a hazard. 
Therefore, the number of  failures from the competing 
risks will reduce the actual number of  failures from 
the event of  interest and consequently, influence the 
estimate of  the probability of  failure from this event. 
In these situations, the cumulative incidence function is 
the appropriate tool for analyzing such data. Cumulative 
incidence function for a specific event, also known as the 
sub-distribution function, is defined as the probability of 
failing from a given cause in the presence of  competing 
events, given that a subject has survived or has already 
failed due to different causes.6,11 In the present study, 
the estimate of  the cumulative incidence for a specific 
event was simultaneously calculated based on the 
estimate of  the overall survival function when all types 
of  events are considered and on the hazard estimate 
of  the specific event. Besides, the cumulative incidence 
function for a specific event depends not only on the 
number of  individuals who have experienced this type 
of  event, but also on the number of  those who have 
not experienced any other event.11 This function is often 
of  interest in epidemiological research and its graphical 
display over the time is intuitive and appealing.11,13,14 To 
analyze the differences in cumulative incidence between 
various patient groups, Gray’s test was used. Comparing 
the cumulative incidence functions gives an idea of  the 
probability of  occurrence of  the event of  interest, and 
therefore can be translated into an actual number of 
patients with the event of  interest.11
Results
Characteristics of  Patients
Of  the 400 hemodialysis patient participants, 41 (10.25%) 
of  them were excluded from the study because they lacked 
complete data on all the predictors. Thus, the samples 
available for the analysis consisted of  359 patients. The 
participants included in these analyses had a mean age 
of  58.93 years and 230 (64.07%) of  them were males. 
The sex ratio was 1.78. The median duration of  follow-
up was 3.12 years and mean age at ESRD diagnosis was 
66.47 years. The baseline characteristics of  our study are 
shown in Table 1. A total of  123 (34.26%) patients died. 
The findings regarding the dead patients of  the center 
showed that of  122 dead patients, 72 (31.30%) of  them 
were males and 50 (38.769%) of  them were females. 
The most common blood type was A. In this study, the 
majority (76.32%) of  people (n = 274) were married.
Comparison of  Different Regression Models
The method of  analysis resulted in markedly different 
estimates. In this study, statistical analysis, based on the 
competing risk model, showed that age, age of  diagnosis, 
level of  education (under diploma), and body mass index 
were significantly associated with death (hazard ratio 
(HR) = 0.98, P < 0.001, HR = 0.99, P < 0.001, HR = 2.66, 
P = 0.008, and HR = 0.98, P < 0.020, respectively). Each 
year increase in age was associated with a 98% increase in 
hazard of  death (Table 2).
Discussion
Competing risks are prevalent most epidemiological 
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Table 1. Characteristics of the Patients
Variables No. (%)
Gender
Male 230 (64.07)
Female 129 (35.93)
Status
Alive 236 (65.74)
Death 123 (34.26)
Job
Unemployed 126 (35.10)
Housewife 71 (19.78)
Employed 115 (32.03)
Retirement 47 (13.09)
Smoking
Yes 140 (39.00)
No 219 (61.00)
Blood group
A 115 (32.03)
B 71 (19.78)
AB 57 (15.88)
O 116 (32.31)
Underlying cause
DM 78 (21.73)
HTN 91 (25.35)
Others 190 (52.92)
Marital status
Single 22 (6.13)
Married 274 (76.32)
Divorced 1 (.28)
Widow 62 (17.27)
Level of education
Illiterate 193 (53.76)
Diploma 102 (28.41)
Under diploma 10 (2.79)
Upper diploma 54 (15.04)
Table 2. Comparison of Different Regression Models Based on Significant 
Variables
Variables HR CI 95% for HR P Value
Competing Risk Model
Age 0.98 (0.97-0.98) <0.001
Age of diagnosis 0.99 (0.998-0.999) <0.001
Level of education
Illiterate (reference) 1 1 1
Under diploma 2.66 (1.23-3.93) 0.008
BMI 0.98 (0.96-0.99) 0.020
Gender female (reference) 1.30 (1.06-1.59) 0.011
Hb 1.05 (1.00-1.11) 0.030
Cox Regression Model
Age 1.03 (1.02-1.04) 0.001
Age of diagnosis 1.00 (1.000-1.001) 0.005
Level of education
Illiterate (reference) 1 1 1
Under diploma 9.6 (0.00-0.74) 0.009
BMI 1.04 (1.01-1.07) 0.002
Gender female (reference) 0.72 (0.50-1.03) 0.080
Hb 0.79 (0.72-.087) 0.001
researches. Failure to correctly account for competing 
events can result in adverse consequences including 
probability overestimation of  the occurrence of  the 
event and magnitude mis-estimation of  relative effects 
of  covariates on the incidence of  the outcome. When 
estimating crude incidence of  the outcome of  interest, 
it is inappropriate to use the complement of  Kaplan-
Meier survival function because this will lead to an 
overestimation of  the incidence of  the outcome of 
interest when competing risks are present. It is important 
to provide the results for all causes and also for both 
cause-specific as well as and sub-distribution hazard 
functions. Our findings showed that the women with 
ESRD had a better survival rate than men. However, the 
difference was not statistically significant. Similar to a 
study by Tabrizi et al.1 in our study, the majority of  patients 
were hypertension (nearly 26%). In contrast, cumulative 
incidence was grossly overestimated by standard survival 
analysis. The Cox proportional regression approach 
requires a proportionality assumption. Our study showed 
that the estimates of  the covariate coefficients were 
different on the cause-specific and also sub-distribution 
hazard models. The cause-specific hazard can be 
modeled using the Cox model which is broadly used in 
epidemiological research. These risk factors are often 
missing from competing risk analyses.15 
Limitations of  the Study
This study had some limitations which need to be 
acknowledged. The most important limitation was the 
lack of  information about incidence and prevalence 
of  ESRD in Iran. As a result, it is suggested that 
further studies to be conducted, using more complete 
information, to estimate the incidence and prevalence in 
Iranian ESRD patients. 
The researchers did not collect follow-up blood 
pressure, medications as well as proteinuria information 
and thus, they cannot comment on the time dependence 
of  the outcomes on these risk factors. Therefore, similar 
studies focusing on the above-mentioned issues are 
subject to further investigation.
Conclusion
 In the presence of  competing risk outcomes, Kaplan-
Meier estimates are biased as they overestimated the 
probability of  the occurrence of  an event of  interest. 
In this paper, 2 common methods have been discussed 
for handling competing risks and their applications in 
regression settings. 
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